文献速递血管炎其他结缔组织病

嗜酸性肉芽肿性多血管炎:疾病认识与管理

Eosinophilic granulomatosis with polyangiitis: understanding the disease and its management.
PubMed 文献 · Rheumatology (Oxford) · 2020-01-01

本文综述嗜酸性肉芽肿性多血管炎(EGPA)以哮喘、血和组织嗜酸性粒细胞增多及小血管炎为特征,临床分ANCA阳性血管炎型与ANCA阴性嗜酸性粒细胞型两个亚群;总体生存良好但常复发,靶向B细胞和IL-5的单克隆抗体正成为传统免疫抑制治疗的替代选择。

要点

  • EGPA临床分两亚群:ANCA阳性以血管炎表现为主,ANCA阴性以嗜酸性粒细胞表现为主。
  • 诊断需与高嗜酸性粒细胞综合征及其他小血管炎鉴别。
  • 总体生存良好但常复发并有持续症状,抗B细胞和抗IL-5单抗是新兴治疗选择。

核心结论

  • EGPA临床异质性大,可分为ANCA阳性血管炎型和ANCA阴性嗜酸性粒细胞型两个主要亚群。
  • 总体生存良好,但患者常复发并遗留持续症状。
  • 靶向B细胞和IL-5等嗜酸性粒细胞生成细胞因子的单克隆抗体正成为传统免疫抑制治疗的有效替代选择。

研究设计与样本

  • 本文为综述,讨论EGPA的核心特征,重点涉及临床表现与管理相关的最重要问题。

主要发现

  • EGPA以哮喘、血和组织嗜酸性粒细胞增多及小血管炎为特征。
  • ANCA阳性亚群以肾小球肾炎、紫癜和单神经炎多发性等血管炎表现为特征。
  • ANCA阴性亚群以肺部浸润和心肌病等嗜酸性粒细胞表现为主。
  • 发病机制尚未完全阐明,可能涉及T细胞、B细胞与嗜酸性粒细胞的相互作用。
  • 总体生存良好,但患者常复发并有持续症状。

关键数值与推荐

  • 临床可分为ANCA阳性血管炎型与ANCA阴性嗜酸性粒细胞型两个主要亚群。

临床怎么用

  • EGPA需与高嗜酸性粒细胞综合征及其他小血管炎鉴别。
  • 根据ANCA状态和临床表型(血管炎型或嗜酸性粒细胞型)识别EGPA亚群。
  • 靶向B细胞和IL-5的单克隆抗体可作为传统免疫抑制治疗的替代选择。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Eosinophilic granulomatosis with polyangiitis is characterized by asthma, blood and tissue eosinophilia and small-vessel vasculitis. The clinical presentation is variable, but two main clinic-pathologic subsets can be distinguished: one hallmarked by positive ANCA and predominant 'vasculitic' manifestations (e.g. glomerulonephritis, purpura and mononeuritis multiplex) and the other by negative ANCA and prominent 'eosinophilic' manifestations (e.g. lung infiltrates and cardiomyopathy). The pathogenesis is not fully understood but probably results from the interplay between T and B cells and eosinophils. Eosinophilic granulomatosis with polyangiitis must be differentiated from several conditions, including hypereosinophilic syndromes and other small-vessel vasculitides. The overall survival is good; however, patients frequently relapse and have persistent symptoms. The recently developed monoclonal antibodies targeting B cells and eosinophilopoietic cytokines such as IL-5 are emerging as valid alternatives to conventional immunosuppressive therapies. In this review, we discuss the essential features of eosinophilic granulomatosis with polyangiitis, with particular respect to the most relevant issues concerning clinical presentation and management.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Trivioli G, Terrier B, Vaglio A, et al. Eosinophilic granulomatosis with polyangiitis: understanding the disease and its management. Rheumatology (Oxford). 2020. PMID: 32348510. doi:10.1093/rheumatology/kez570

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。